Alerts

New use of benzodiazepines associated with increased risk of dementia [BMJ, 345, Sept, 2012]
Beta blockers may not save lives [JAMA, Oct, 2012]
No added benefits for clopidogrel with aspirin [NEJM, Aug 30, 2012]
NSAIDs Increase Cardiovascular Risk, Post MI [Circultion, Sep 2012, Full Text]
Statins May Increase Pneumonia Risk [Report]
Statins accelerate coronary artery calcification [Diabetes Care Full Text]
Side Effects Prevent Statin Use [J Clin Lipidol Abstract | Report]
Cefepime and Epilepsy Risk [FDA Statement | Report]
Azithromycin and Cardivascular Risk [NEJM Abstract | FDA Statement]
Pioglitazone Increases Bladder Cancer Risk [BMJ Full Text | Report | Report]
Misleading Erythropoetin Trials [Report]
Whistleblower Suit Claims Pioglitazone Cover-up [Report]
New FDA Watch List [FDA Info | Report]
Safety Label Changes to Finasteride [FDA Info | Report]
Phthalates Linked to Diabetes [Diabetes Care Full text | Report]
Only antibiotics effective for early and uncomplicated appendicitis[BMJ Full text]
Fluoroquinolones Linked to Retinal Detachments[JAMA Abstract | Report]
Amoxycillin does not help acute sinusitis at day 3 [JAMA Article | Report]
Sulfonylureas and insulin may inrease risk of pancreatic cancer [AJG Article | Report | Report]
Tamiflu Data Questioned by Cochrane Review [Cochrane Review | Report]
Aspirin for Primary Prevention: Risks Outweigh Benefits[Report]
Aspirin use may increase macular degeneration[Report]
Statins increase diabetes risk[Report | More]
Addition of niacin to statins not helpful [NEJM article | Report]
Systematic review questions efficacy of Flu vaccine[Lancet Infect Dis Full Text]
Four drugs that harm the elders most[NEJM Abstract | Report]
Acetaminophen 4g/day can be fatal [B J Clin Pharm Full Text | Report]
Vitamin Supplements Associated With Increased Risk for Death[Arch Int Med | Report | More]
Incretin Therapy: Breakthrough or Bust?[Report]
Cardiovascular risk of NSAIDs[Plos Medicine Full Text]
Saw Palmetto Extract Ineffective Against Urinary Symptoms[JAMA Abstract| Report]
Sitagliptin and exenatide increase the risks of pancreatitis, pancreatic cancer and thyroid cancer [Gastroenterology Full Text | Editorial | Report]
Chronic NSAID Use Increases Risk of Renal Cell Cancer[Arch Int MedAbstract | Editorial | Report]
NSAID Use During Pregnancy Increases Spontaneous Abortion[CMAJ Full Text]
Adenoidectomy does not reduce risks of URTI[BMJ Full text]
Brain stents increase strokes and deaths[NEJM Full text]
Most drugs for diabetes, except metformin, are not safe[Full Text | Report]
Chronic NSAID Use Doubles Cardiovascular Deaths in Elderly[AJM Abstract | Report | Report]
NSAIDs Increase the Risk of Atrial Fibrillation[BMJ Full Text | Editorial |Report]
Possible Link Betwen Insulin Glargine and Cancer[Diabetologia]
FDA Warns of Serious Risks Associated With Liraglutide[Report]
Higher Calcium Intake May Not Lower Risk for Fractures and Osteoporosis[BMJ Full Text | Report]
Pioglitazone linked to bladder cancer [Diabetes Care Full text | Report]
NSAIDs for a week increase risk of recurrent MI and death[Circulation Full text | Report]
Proton Pump Inhibitors Linked to Fracture Risk [Ann Fam Med Full text | Report]
Statins Increase Diabetes Risk: More Evidence[JACC Abstract | Report]
ARB/ACE-Inhibitor Combination a Risk[Full text | Report]
Antibiotics may alter protection offered by gut commensals aginst the flu virus in the lungs[Abstract | Report]
Improved outcomes associated with metformin therapy in patients with diabetes and heart failure Abstract | Report]
Regular NSAID use may Lead to Erectile Dysfunction[Abstract | Report]
Topiramate Linked to Birth Defects[FDA Alert | Report]
ACP Guideline Discourages Intensive Insulin Therapy[Full Text at Annals Int Med | Full Text at Annals Int Med | Report]
Antibiotic use in childhood may increase the risk of inflammatory bowel disease[Abstract from Gut | Press Release]
US FDA Watching More Drugs[FDA Alert]
Statins of doubtful value in primary prevention: Cochrane Review[Full Text]
NSAIDs Increase Cardiovascular Risk[Full Text BMJ | Report]
Propoxyphene Withdrawn From US Market[FDA Alert | Report]
Vitamin supplementation worsens diabetic nephropathy[Free Full text JAMA | Report]
Study on rivastigmine as an adjunct to haloperidol for delirium halted due to increased mortality[Abstract The Lancet]
Glucosamine may increase diabetes risk[Abstract J Endocrinolo | Report]
HRT increases breast cancer deaths[Abstract JAMA | Report | Report]
Increased risk of fractures with bisphosphonates[See FDA Alert | Report]
Proton Pump Inhibitors increase adverse outcome after MI[See Full Text | Report]
Rosiglitazone banned in India [See] and Sibutramine withdrawn by Abbott [See 1,2]
Increased Risk of Esophageal Cancer From Oral Bisphosphonates [BMJ. 2010 Sep 1 | Report]
Pioglitazone linked to bladder cancer: FDA [FDA Alert | Report]
NSAID Use Associated With Future Stroke in Healthy Population [Report]
Pioglitazone as risky as rosiglitazone, study finds [Wertz DA et al. Circulation: Cardiovascular Quality and Outcomes. Aug 24, 2010 | Report]
Angiotensin-receptor blockade may increase the risk of cancer [Sipahi I et al. Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials. Lancet Oncol. 2010 Jul;11(7):627-636. Epub 2010 Jun 11.]
FDA Documents Find Significant Risks for Rosiglitazone [See 1, 2, 3, 4, 5,6, 7][Updated Aug 1, 2010]
Statins may increase diabetes risk [Naveed Sattar et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials The Lancet, 17 February 2010 | Reuters Report]
Thiazolidinedione Use Increases Risk of Fractures in Patients with Type 2 Diabetes Mellitus [Zeina A. Habib et al. The Journal of Clinical Endocrinology & Metabolism Feb 2009;95(2):592-600][More]
Oseltamivir neither effective nor safe: BMJ [BMJ Dec 8, 2009]
Diclofenac may cause liver failure [FDA Alert]
PPIs reduce the efficacy of Clopidogrel [FDA Alert; FDA Alert]
No checks on drug companies bribing doctors [See Report]
Swine flu vaccine approved without adequate tests [FDA Approval; Product Details]
Swine flu vaccine may cause neuromuscular paralysis : Leaked letter reveals concern of neurologists over 25 deaths in America [See Report]
FDA Warns of Increased Cancer Risk With TNF Blockers in Children [See FDA, Report]
Wyeth used ghost writers to promote HRT [See 1, 2, 3, 4]
Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone [See BMJ, Report]
Increased risk of cancer with TNF blockers, warns FDA [See 1, 2, 3]
Insulin Analogue Glargine Possibly Increases Cancer Risk [See 1, 2]
Chantix and Zyban to Receive Boxed Warnings for Serious Neuropsychiatric Symptoms [See]
FDA May Restrict Acetaminophen [See]
New Safety Labeling for Leukotriene Modifiers [See]
More Evidence Links Glitazones to Broken Bones [See]
HRT Increases Risk for Death from Non-Small-Cell Lung Cancer [See]
British scientists ask WHO to condemn homeopathy for diseases such as HIV [See]
The Lancet critique on Bill & Melinda Gates Foundation grant pattern [See; See Report]
Elsevier published 6 fake journals [See | More]
Efalizumab being withdrawn from U.S. market following PML cases [See | More]
Celecoxib: A big research fraud stands exposed [R Prasad :: The Hindu | Editorial ::The Hindu]
Reducing Heart Rate in Hypertension May Be Harmful [See]
Muscle Pain and Weakness With Statin Treatment May Herald ALS [See]
Ipratopium Linked to Increased Mortality Risk [See]
FDA Is Watching 20 Drugs [See]
FDA Investigating Possible Link Between Ezetimibe/Simvastatin and Increased Cancer Risk [FDA | Report | Report]
Review of the Use of Muscle Relaxants for Musculoskeletal Conditions
FDA Requests Boxed Warnings on Fluoro-quinolone Antimicrobial Drugs
Rosiglitazone-Associated Fractures in Type 2 Diabetes
Anti depressants no better than placebo
Possible Link Between Montelukast and Suicidality: Early Communication About an Ongoing Safety Review by US FDA
Exenatide may cause pancreatitis: FDA reviews 30 postmarketing reports
Information on Long-Acting Hydrocodone-Containing Cough Product

COX-2 Selective and Non-Selective Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) increase risk for cardiovascular events

NIH Halts Use of COX-2 Inhibitor in Large Cancer Prevention Trial
MRI Not Required for Knee Osteoarthritis, Study Suggests

 

Comments are closed